By Stephen Nakrosis

Elanco Animal Health Inc. (ELAN) said it received a second request for information from the U.S. Federal Trade Commission regarding its planned acquisition of Bayer AG's animal health business.

In August, the two companies announced a deal that will see Elanco acquire the unit in a cash-and-stock deal valued at $7.6 billion. At the time, the companies said the transaction was expected to close by the middle of next year.

Elanco said Monday, "The request was anticipated as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the review continues to progress as expected."

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

December 09, 2019 18:30 ET (23:30 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Bayer
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Bayer